Glenmark Pharmaceuticals Inc., USA Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Glenmark Pharmaceuticals Inc., USA Pharmaceutical Import Records from India — 15 Products, $123.6M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Glenmark Pharmaceuticals Inc., USA — Pharmaceutical Importer Profile (2026) | 15 Products, $123.6M Trade | TransData Nexus

Glenmark Pharmaceuticals Inc., USA

Pharmaceutical Importer · United States · Cardiovascular Focus · $123.6M Total Trade · DGFT Verified

Glenmark Pharmaceuticals Inc., USA is a pharmaceutical importer based in United States with a total trade value of $123.6M across 15 products in 8 therapeutic categories. Based on 3,231 verified import shipments from Indian Customs (DGFT) records, Glenmark Pharmaceuticals Inc., USA is the #1 buyer in 2 products including Ondansetron, Indomethacin. Glenmark Pharmaceuticals Inc., USA sources from 4 verified Indian suppliers, with Glenmark Pharmaceuticals Limited accounting for 99.3% of imports.

Glenmark Pharmaceuticals Inc., USA — Import Portfolio & Supplier Network

Glenmark Pharmaceuticals Inc., USA import network — 15 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Glenmark Pharmaceuticals Inc., USA?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Glenmark Pharmaceuticals Limited	$173.0M	5,753	99.3%
Mankind Pharma Limited	$737.0K	22	0.4%
Caplin Steriles Limited

What Formulations Does Glenmark Pharmaceuticals Inc., USA Import?

Formulation	Value	Ships
Omeprazole dr cap 40MG	$5.4M	148
Ondansetron odt 4MG	$2.8M	121
Omeprazole dr cap 20MG	$2.6M	75
Mupirocin oint 2% 22GM	$2.5M	160
Omeprazole dr cap 40MG	$1.7M	50
Rosuvastatin TAB 40MG	$1.4M	33
Abiraterone ace TAB 250MG	$1.3M	25
Zonisamide cap 100MG	$1.2M	29
Olmesartan medox TAB 40MG	$1.1M	23
Imiquimod cream 5% 0.25GM	$1.0M	25
Rosuvastatin TAB 10MG	$988.5K	27
Hailey fe 1.5/30 TAB 1.5MG/30mcg-75MG	$986.2K	25
Olmesartan medox TAB 40MG	$912.2K	22
Abiraterone ace TAB 500MG	$897.2K	18
Estradiol vag inserts 10mcg	$864.8K	23

Glenmark Pharmaceuticals Inc., USA imports 2,550 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 15 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Rosuvastatin	Cardiovascular	$30.4M	609	3.9%	3
2	Omeprazole	Gastrointestinal	$27.5M	649	2.8%	7
3	Naproxen	Analgesics & Antipyretics	$12.7M	266	8.2%	2
4	Ondansetron	Gastrointestinal	$11.7M	448	6.3%	1
5	Verapamil	Cardiovascular	$8.0M	165	4.7%	4
6	Carvedilol	Cardiovascular	$7.4M	223	6.4%	5
7	Gabapentin	CNS & Psychiatric	$6.9M	138	0.8%	9
8	Atovaquone	Antimalarial & Antiparasitic	$3.9M	78	0.3%	2
9	Pravastatin	Cardiovascular	$2.9M	57	7.2%	3
10	Telmisartan	Cardiovascular	$2.6M	102	0.0%	10
11	Fluconazole	Antifungals	$2.6M	95	1.8%	7
12	Clotrimazole	Antifungals	$2.1M	179	2.3%	4
13	Indomethacin	Analgesics & Antipyretics	$2.0M	95	11.3%	1
14	Theophylline	Respiratory	$1.5M	49	6.4%	4
15	Clindamycin	Antibiotics	$1.4M	78	1.5%	18

Glenmark Pharmaceuticals Inc., USA imports 15 pharmaceutical products across 8 categories into United States totaling $123.6M. The company is the #1 buyer for 2 products: Ondansetron, Indomethacin.

Glenmark Pharmaceuticals Inc., USA — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Glenmark Pharmaceuticals Inc., USA, is a pharmaceutical importer and buyer based in the United States, specializing in the procurement of finished pharmaceutical formulations from India. The company operates as a subsidiary of Glenmark Pharmaceuticals Limited, an Indian multinational pharmaceutical company headquartered in Mumbai. Glenmark Pharmaceuticals Limited was founded in 1977 by Gracias Saldanha and has since expanded its global presence, including a significant footprint in the U.S. market.

In the United States, Glenmark Pharmaceuticals Inc. plays a pivotal role in the pharmaceutical supply chain by importing a diverse range of finished dosage forms, including tablets, capsules, syrups, and injections. These products are sourced primarily from Indian manufacturers and are distributed to various stakeholders within the U.S. healthcare system, including wholesalers, healthcare providers, and patients. The company's operations are integral to ensuring the availability of affordable and high-quality generic medications in the U.S. market.

2Distribution Network

Glenmark Pharmaceuticals Inc., USA, maintains a robust distribution network across the United States, with its primary warehouse located at 4147 Goldmine Rd, Monroe, North Carolina 28110. This strategic location facilitates efficient logistics and timely delivery of pharmaceutical products to various regions within the country. The company's logistics capabilities are designed to handle a diverse portfolio of finished pharmaceutical formulations, ensuring compliance with U.S. regulatory standards and meeting the demands of the U.S. healthcare market.

3Industry Role

In the U.S. pharmaceutical supply chain, Glenmark Pharmaceuticals Inc., USA, functions primarily as a pharmaceutical importer and distributor. The company sources finished pharmaceutical formulations from Indian manufacturers and supplies them to various stakeholders within the U.S. healthcare system. This role is crucial in enhancing the availability of generic medications, thereby contributing to the affordability and accessibility of healthcare in the United States.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Glenmark Pharmaceuticals Inc., USA

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Glenmark Pharmaceuticals Inc., USA, exhibits a high degree of sourcing concentration, with 99.3% of its imports originating from Glenmark Pharmaceuticals Limited, India. This significant dependency on a single supplier indicates a strategic choice to maintain consistency in product quality and supply chain efficiency. The substantial volume of shipments—5,753 in total—suggests a stable and long-term relationship between the two entities. However, this concentration also presents potential risks, such as supply chain disruptions due to unforeseen events affecting the primary supplier.

2Supply Chain Resilience

The resilience of Glenmark Pharmaceuticals Inc., USA's supply chain is closely tied to its reliance on Glenmark Pharmaceuticals Limited, India. While this centralized sourcing strategy ensures uniformity in product quality, it also exposes the company to risks associated with geopolitical events, regulatory changes, or operational challenges in India. The limited number of backup suppliers—Mankind Pharma Limited, Caplin Steriles Limited, and Immacule Lifesciences Private Limited—constitutes a small fraction of the total imports, indicating a lack of diversification in the supply chain. This limited diversification may impact the company's ability to mitigate supply chain disruptions effectively.

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation of pharmaceutical products. The FDA enforces the Federal Food, Drug, and Cosmetic Act (FD&C Act), which sets forth the legal framework for drug imports, ensuring that all imported drugs meet the same standards of quality, safety, and effectiveness as domestically produced drugs.

The FDA's regulatory framework for pharmaceutical imports includes requirements for facility registration, drug listing, and compliance with Good Manufacturing Practice (GMP) standards. Foreign drug establishments whose products are imported into the U.S. must register with the FDA and list all their drug products in commercial distribution in the United States. Additionally, imported drugs must comply with FDA's standards for quality, safety, and effectiveness, and must be manufactured in accordance with FDA-approved applications.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products entering the United States are governed by the FDA. All foreign drug establishments whose products are imported into the U.S. are required to register with the FDA and list all their drug products in commercial distribution in the United States. Additionally, imported drugs must comply with FDA's standards for quality, safety, and effectiveness, and must be manufactured in accordance with FDA-approved applications.

Glenmark Pharmaceuticals Inc., USA — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Glenmark Pharmaceuticals Inc., USA, focuses its product strategy on importing finished pharmaceutical formulations across various therapeutic categories, with a significant emphasis on cardiovascular, gastrointestinal, and analgesics & antipyretics. This focus aligns with the company's objective to provide a comprehensive range of medications that address prevalent health conditions in the United States. The substantial import values in these categories indicate strong market demand and the company's commitment to meeting the therapeutic needs of the U.S. population.

2Sourcing Profile

Glenmark Pharmaceuticals Inc., USA, primarily sources generic drug formulations from India, leveraging the country's established pharmaceutical manufacturing capabilities. The company's sourcing strategy emphasizes finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, rather than raw active pharmaceutical ingredients (APIs) or bulk drugs. This approach allows Glenmark to offer a diverse portfolio of ready-to-market products, catering to various therapeutic areas and patient needs in the U.S. market.

3Market Positioning

Seller's Guide — How to Become a Supplier to Glenmark Pharmaceuticals Inc., USA

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter Glenmark Pharmaceuticals Inc., USA's sourcing network. The company's current sourcing pattern, with a heavy reliance on Glenmark Pharmaceuticals Limited, indicates potential for diversification. Indian exporters seeking to become alternative suppliers should focus on meeting the stringent quality and regulatory standards required by the U.S. market, as well as demonstrating the ability to supply a diverse range of finished pharmaceutical formulations.

2Requirements & Qualifications

Indian exporters aiming to supply Glenmark Pharmaceuticals Inc., USA, and the broader U.S. market must obtain FDA approval for their drug products. This involves registering their manufacturing facilities with the FDA, listing all drug products intended for import, and ensuring compliance with Good Manufacturing Practice (GMP) standards. Additionally, drug products must meet FDA's standards for quality, safety, and effectiveness, and must be manufactured in accordance with FDA-approved applications.

3How to Approach

Frequently Asked Questions — Glenmark Pharmaceuticals Inc., USA

What products does Glenmark Pharmaceuticals Inc., USA import from India?

Glenmark Pharmaceuticals Inc., USA imports 15 pharmaceutical products across 8 categories. Top imports: Rosuvastatin ($30.4M), Omeprazole ($27.5M), Naproxen ($12.7M), Ondansetron ($11.7M), Verapamil ($8.0M).

Who supplies pharmaceuticals to Glenmark Pharmaceuticals Inc., USA from India?

Glenmark Pharmaceuticals Inc., USA sources from 4 verified Indian suppliers. The primary supplier is Glenmark Pharmaceuticals Limited (99.3% of imports, $173.0M).

What is Glenmark Pharmaceuticals Inc., USA's total pharmaceutical import value?

Glenmark Pharmaceuticals Inc., USA's total pharmaceutical import value from India is $123.6M, based on 3,231 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Glenmark Pharmaceuticals Inc., USA focus on?

Glenmark Pharmaceuticals Inc., USA imports across 8 categories. The largest: Cardiovascular (41.5%), Gastrointestinal (31.7%), Analgesics & Antipyretics (11.9%).

Get Full Glenmark Pharmaceuticals Inc., USA Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 5 company name variants from customs records. For current shipment-level data, contact TransData Nexus.